Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
0.9226
+0.0506 (5.80%)
Oct 28, 2026, 2:34 PM EDT - Market open
Tiziana Life Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.18 | 4.01 | 3.72 | 1.18 | 18.12 | 42.19 |
Cash & Short-Term Investments | 3.18 | 4.01 | 3.72 | 1.18 | 18.12 | 42.19 |
Cash Growth | -56.17% | 7.68% | 214.79% | -93.47% | -57.04% | -35.91% |
Other Receivables | 4.32 | 4.08 | 3.64 | 5.93 | 5.86 | 5.27 |
Receivables | 4.32 | 4.08 | 3.64 | 5.93 | 5.86 | 5.27 |
Prepaid Expenses | 1.94 | 0.29 | 0.09 | 0.1 | 0.17 | 1.19 |
Other Current Assets | - | 0.17 | 0.05 | 0.12 | 0.13 | 0.04 |
Total Current Assets | 9.44 | 8.55 | 7.51 | 7.34 | 24.28 | 48.68 |
Property, Plant & Equipment | 0.99 | 0.5 | 0.19 | 0.29 | 0.39 | 0.02 |
Long-Term Investments | 1.24 | 2.44 | 3.59 | 4.55 | 1.81 | - |
Other Intangible Assets | - | - | - | - | - | 0.13 |
Total Assets | 11.66 | 11.5 | 11.28 | 12.18 | 26.48 | 48.83 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 10.48 | 7.17 | 5.58 | 4.14 | 4.96 | 4.41 |
Accrued Expenses | 2.65 | 3.29 | 1.65 | 2.25 | 1.57 | 1.78 |
Current Portion of Leases | 0.11 | 0.22 | 0.11 | 0.14 | 0.12 | - |
Current Unearned Revenue | 0.34 | 0.53 | - | - | - | - |
Other Current Liabilities | 0.01 | -0 | 0.01 | 0.01 | 0.01 | 1.37 |
Total Current Liabilities | 13.58 | 11.21 | 7.35 | 6.54 | 6.66 | 7.55 |
Long-Term Leases | 0.83 | 0.23 | - | 0.11 | 0.24 | - |
Total Liabilities | 14.41 | 11.44 | 7.35 | 6.65 | 6.91 | 7.55 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.13 | 0.12 | 0.11 | 0.1 | 0.1 | 0.1 |
Additional Paid-In Capital | 43.44 | 34.66 | 23.11 | 16.49 | 15.6 | 15.6 |
Retained Earnings | -175.5 | -163.11 | -144.83 | -133.68 | -116.26 | -108.06 |
Treasury Stock | - | - | - | -1.57 | -1.32 | - |
Comprehensive Income & Other | 129.18 | 128.38 | 125.55 | 124.19 | 121.46 | 133.65 |
Shareholders' Equity | -2.75 | 0.05 | 3.94 | 5.54 | 19.57 | 41.28 |
Total Liabilities & Equity | 11.66 | 11.5 | 11.28 | 12.18 | 26.48 | 48.83 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.93 | 0.46 | 0.11 | 0.25 | 0.37 | - |
Net Cash (Debt) | 2.25 | 3.55 | 3.62 | 0.94 | 17.76 | 42.19 |
Net Cash Growth | -68.56% | -1.77% | 286.54% | -94.73% | -57.91% | -35.37% |
Net Cash Per Share | 0.02 | 0.03 | 0.03 | 0.01 | 0.17 | 0.43 |
Filing Date Shares Outstanding | 128.03 | 120.51 | 111.46 | 101.51 | 100.59 | 102.27 |
Total Common Shares Outstanding | 128.03 | 120.51 | 111.46 | 101.51 | 100.59 | 102.27 |
Working Capital | -4.14 | -2.66 | 0.16 | 0.8 | 17.62 | 41.13 |
Book Value Per Share | -0.02 | 0.00 | 0.04 | 0.05 | 0.19 | 0.40 |
Tangible Book Value | -2.75 | 0.05 | 3.94 | 5.54 | 19.57 | 41.15 |
Tangible Book Value Per Share | -0.02 | 0.00 | 0.04 | 0.05 | 0.19 | 0.40 |